Ontario Drug Policy Research Network
Ontario Drug Policy Research Network is a Toronto-based research organization founded in 2008 that conducts multi-provincial drug policy research — notably on opioid dispensing — to inform Canadian government health agencies and policy makers through published evidence and analysis.
- Company typePrivate
- Founded2008
- HeadquartersToronto, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Ontario Drug Policy Research Network does
Ontario Drug Policy Research Network (ODPRN) is a Toronto-based research organization founded in 2008 that conducts drug policy research and analysis to inform public health decision-making in Canada. The network's primary work involves studying drug utilization, safety, and effectiveness — with a notable focus on opioid dispensing trends across multiple Canadian provinces — to generate evidence that supports clinical practice guidelines and policy formulation by government health agencies and policy makers.
The organization's core technology is its research network itself: a coordinated multi-provincial analytic capability that draws on academic and health-system data to produce findings for policy consumption. ODPRN does not operate as a commercial product vendor; there are no disclosed products, platforms, APIs, or proprietary technology stacks in the input data, and no AI/ML capabilities are evidenced. Output is disseminated through academic publications and earned media coverage of published research rather than through direct sales channels.
ODPRN's business model is consistent with a grant-funded research entity. No pricing model, no commercial customers, and no disclosed revenue are present in the data; the network's customer base is identified as government health agencies and policy makers served on a vertical basis. The organization is private, Canadian-domiciled (Ontario), operates with 11–50 employees, and has no disclosed parent company, subsidiaries, funding rounds, M&A activity, or leadership changes on record.
Ontario Drug Policy Research Network firmographics
Firmographics- Name
- Ontario Drug Policy Research Network
- Legal name
- Ontario Drug Policy Research Network
- Website
- https://odprn.ca
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ontario Drug Policy Research Network is a Toronto-based research organization founded in 2008 that conducts multi-provincial drug policy research — notably on opioid dispensing — to inform Canadian government health agencies and policy makers through published evidence and analysis.
- Ownership category
- akta.pro rank
Ontario Drug Policy Research Network industry classification
Industry- Product category
- Drug Policy Research
- SIC
- Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
- akta.pro industry
- Policy, Regulatory & Public Affairs ResearchBusiness & Public Services/Professional Services (Legal, Accounting, Consulting)/Research, Analytics & Expert ServicesPharmacovigilance, Medication Safety & Controlled Substance Diversion Monitoring
Keywords
Where Ontario Drug Policy Research Network is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Markets served
Ontario Drug Policy Research Network business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D
Marketing channels1 record
Ontario Drug Policy Research Network product offering
Product offeringCore offering
Ontario Drug Policy Research Network is a research network that conducts studies on drug utilization, safety, and effectiveness — with particular focus on opioid dispensing — to inform healthcare policy and clinical practice guidelines. It produces rigorous evidence-based analysis across multiple Canadian provinces to support drug policy decisions.
Product overview
No product or service information available in the source data. Ontario Drug Policy Research Network appears to be a research organization focused on drug policy research, but no specific product offerings, platforms, or services are described in the provided sources.
Differentiator
Problem solved
Functional benefit
Companies that use Ontario Drug Policy Research Network
Customer profileSegments1 record
Ideal customer profiles1 record
Ontario Drug Policy Research Network technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Ontario Drug Policy Research Network partnerships and signals
Strategic signalScale indicators1 record
Recent moves2 records
Expansion highlights2 records
Ontario Drug Policy Research Network competitors and assessment
Company assessmentBroad incumbents
- Canadian Institute for Health Information (CIHI): Canadian health data organization providing population-level drug and health system data. Comparable to ODPRN in providing multi-provincial Canadian health data inputs that support drug policy decisions.
- Institute for Clinical and Economic Review (ICER): US-based organization producing drug value assessments and policy-facing research. Comparable in that it conducts evidence-based drug effectiveness and policy analysis, though it operates at a larger, broader scale than ODPRN.
- National Institute for Health and Care Excellence (NICE): UK body providing evidence-based guidance on drugs and health technologies for the NHS. Comparable in that it produces drug effectiveness and policy guidance derived from rigorous research, though at national scale and with broader scope.
Regional players
- Centre for Addiction and Mental Health (CAMH): Toronto-based Canadian academic health science centre with active substance use and addiction research. Comparable in its research focus on opioid/substance use policy-relevant evidence in Canada.
Direct peers
- Canadian Centre on Substance Use and Addiction (CCSA): Canadian not-for-profit providing evidence and policy advice on substance use, including opioids. Directly comparable to ODPRN's focus on opioid-related drug policy research for Canadian decision-makers.
- Drug Safety and Effectiveness Network (DSEN): CIHR-funded Canadian network generating real-world evidence on drug safety and effectiveness. Directly comparable as a Canadian research network informing drug utilization and policy decisions.
- Canadian Agency for Drugs and Technologies in Health (CADTH): Canadian health technology assessment agency that evaluates drugs and informs federal/provincial reimbursement and policy decisions. Highly comparable to ODPRN as a Canadian evidence-based body shaping drug policy.
- Patented Medicine Prices Review Board (PMPRB): Canadian federal agency that analyzes drug pricing and utilization trends to inform pharmaceutical policy. Comparable to ODPRN's role of using drug utilization data to inform Canadian drug policy.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Ontario Drug Policy Research Network social profiles
Digital presenceOntario Drug Policy Research Network financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ontario Drug Policy Research Network leadership team
Management profileNumber of profiles
Ontario Drug Policy Research Network funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ontario Drug Policy Research Network M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ontario Drug Policy Research Network
What does Ontario Drug Policy Research Network do?
Ontario Drug Policy Research Network is a research network that conducts studies on drug utilization, safety, and effectiveness — with particular focus on opioid dispensing — to inform healthcare policy and clinical practice guidelines. It produces rigorous evidence-based analysis across multiple Canadian provinces to support drug policy decisions.
Is Ontario Drug Policy Research Network a public or private company?
Ontario Drug Policy Research Network is a private company. It is classified as unknown and is currently operating.
When was Ontario Drug Policy Research Network founded?
Ontario Drug Policy Research Network was founded in 2008. It employs 11 to 50 people.
Where is Ontario Drug Policy Research Network based?
Ontario Drug Policy Research Network is headquartered in Toronto, Canada, in the North America region.
Who are Ontario Drug Policy Research Network's main competitors?
Broad incumbents on record are Canadian Institute for Health Information (CIHI), Institute for Clinical and Economic Review (ICER) and National Institute for Health and Care Excellence (NICE). Centre for Addiction and Mental Health (CAMH) is listed as a regional player. Direct peers are Canadian Centre on Substance Use and Addiction (CCSA), Drug Safety and Effectiveness Network (DSEN), Canadian Agency for Drugs and Technologies in Health (CADTH) and Patented Medicine Prices Review Board (PMPRB).
Does Ontario Drug Policy Research Network have an API?
No public API is recorded for Ontario Drug Policy Research Network.
What industry is Ontario Drug Policy Research Network in?
Ontario Drug Policy Research Network's product category is Drug Policy Research. Its primary akta.pro industry code is BPAHALAF, Policy, Regulatory & Public Affairs Research, with a secondary code of HLAFALAN, Pharmacovigilance, Medication Safety & Controlled Substance Diversion Monitoring. Its SIC code is 8000.